Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 963,027	$ 1,013,540	$ 936,240
Cost of products sold	637,347	638,702	594,141
Gross profit	325,680	374,838	342,099
Selling expenses	110,043	105,341	102,528
General and administrative expenses	107,249	106,760	94,794
Research and development expenses	23,869	26,193	20,935
Amortization of intangibles	29,946	29,396	26,001
Income from operations	54,573	107,148	97,841
Interest and debt expense	32,426	37,957	27,942
Investment (income) loss, net	(1,302)	(1,759)	(315)
Foreign currency exchange loss (gain), net	3,179	1,826	(2,189)
Other (income) expense, net	25,775	7,597	(2,072)
Income before income tax expense	(5,505)	61,527	74,475
Income tax (benefit) expense	(367)	14,902	26,046
Net income (loss)	$ (5,138)	$ 46,625	$ 48,429
Average basic shares outstanding (in shares)	28,738	28,728	28,600
Average diluted shares outstanding (in shares)	28,738	29,026	28,818
Basic income (loss) per share (in dollars per share)	$ (0.18)	$ 1.62	$ 1.69
Diluted income (loss) per share (in dollars per share)	(0.18)	1.61	1.68
Dividends declared per common share (in dollars per share)	$ 0.28	$ 0.28	$ 0.28